Famotidine
LDOS-21-001-02
Phase 2 small_molecule terminated
Quick answer
Famotidine for 2019 Novel Coronavirus Disease is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 3 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- 2019 Novel Coronavirus Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated